- and
therapy of
aplastic anemia due to bone
marrow insufficiency. Two
antithymocyte globulin (ATG)
agents licensed for
clinical use in the
United States...
- failure,
including aplastic anemia and has
additional off-label uses.
Antithymocyte globulin (ATG) was
originally developed as one of
various tested preparations...
- antibiotics. Drug
therapy may
include the
medications lenalidomide,
antithymocyte globulin, and azacitidine. Some
people can be
cured by chemotherapy...
-
considered second-line therapy.
Treatment often includes a
course of
antithymocyte globulin (ATG) and
several months of
treatment with
ciclosporin to modulate...
- the patient's
thymocytes or lymphocytes. The
antilymphocyte (ALG) and
antithymocyte antigens (ATG) are
being used. They are part of the steroid-resistant...
-
Chari RS, Wood JH, et al. (May 2007). "Serum
sickness following rabbit antithymocyte-globulin
induction in a
liver transplant recipient: case
report and...
- WHO version. L04AA03
Antilymphocyte immunoglobulin (horse) L04AA04
Antithymocyte immunoglobulin (rabbit) L04AA06
Mycophenolic acid L04AA15 Alefacept...
-
evidence base are
often tried to
control the disease.
These include antithymocyte globulin and
mycophenolate mofetil; some
reports have
shown improvements...
- Brennan, DC,
Daller JA, Lake KD,
Cibrik D, Del
Castillo D (2006). "Rabbit
antithymocyte globulin versus basiliximab in
renal transplantation". N Engl J Med...
- regulation). He
directed the
first multicenter clinical trial using antithymocyte globulin for the
treatment of
aplastic anemia in the
United States....
